WALTHAM, Mass.--(BUSINESS WIRE)--Deciphera Pharmaceuticals, a clinical-stage biopharmaceutical company focused on addressing key mechanisms of tumor drug resistance, announced today that it has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results